Acrivon Therapeutics, Inc. Common Stock (ACRV) vs Equillium, Inc. (EQ)
A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and Equillium, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.89HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
EQ
Equillium, Inc.
$1.43HealthcareDelayed quote: Oct 6, 2026, 1:30 PM EDT
Total return — ACRV vs EQ
growth of $100 · dividends reinvested · last 4yACRV -88.1% (-41.3%/yr)EQ -15.7% (-4.2%/yr)EQ compounded faster over this window
Log scale — wide-divergence pair
ACRV EQ
ACRV vs EQ: by the numbers
- •EQ is the larger company ($90M vs $81M market cap).
Metrics side by side
Valuation
| Metric | ACRV | EQ |
|---|---|---|
| P/B ratio | 0.93 | 1.61 |
Profitability
| Metric | ACRV | EQ |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -85.65% | -32.15% |
| ROIC | -88.28% | -34.10% |
Growth (annualized)
| Metric | ACRV | EQ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -26.99% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.